Literature DB >> 408427

Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine.

G M Baer, J H Shaddock, S A Moore, P A Yager, S S Baron, H B Levy.   

Abstract

Addition of interferon to ineffective rabies virus vaccines by the local injection of either exogenous interferon or a potent interferon inducer (a complex of polyriboinosinic-polyribocytidylic acid containing poly-L-lysine and carboxymethylcellulose) into the footpads of mice previously challenged with rabies virus dramatically reduced the mortality rate. A significant reduction in mortality rate was also noted when the interferon system was administered to rhesus monkeys, but only when treatment was given 6 hr after challenge with rabies virus. Since the monkeys were given an overwhelming challenge of virus, the treatment had to be given quickly to obtain results comparable to those in mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408427     DOI: 10.1093/infdis/136.2.286

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.

Authors:  G M Baer; S A Moore; J H Shaddock; H B Levy
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Authors:  Satoko Yamaoka; Naoto Ito; Seii Ohka; Shohei Kaneda; Hiroko Nakamura; Takahiro Agari; Tatsunori Masatani; Keisuke Nakagawa; Kazuma Okada; Kota Okadera; Hiromichi Mitake; Teruo Fujii; Makoto Sugiyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects.

Authors:  H X Lin; C Gontier; M F Saron; P Perrin
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Immune sera and antiglycoprotein monoclonal antibodies inhibit in vitro cell-to-cell spread of pathogenic rabies viruses.

Authors:  D L Lodmell; L C Ewalt
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  Enhanced antibody responses in mice by combined administration of interferon with rabies vaccine.

Authors:  K Mifune; K Mannen; S Cho; H Narahara
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer.

Authors:  C T Cho; K K Feng; V P McCarthy; M F Lenahan
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Solid-phase radioimmunoassay techniques for the detection of African swine fever antigen and antibody.

Authors:  J R Crowther; R C Wardley; P J Wilkinson
Journal:  J Hyg (Lond)       Date:  1979-10

8.  Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors.

Authors:  H Moser; F Behrens; R Ziegelmaier; J Hilfenhaus; R Mauler
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

9.  Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death.

Authors:  M Kende; H W Lupton; W L Rill; P Gibbs; H B Levy; P G Canonico
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

10.  Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.

Authors:  J P Wong; E G Saravolac; D Sabuda; H B Levy; M Kende
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.